
Fusion Antibodies PLC
LSE:FAB

Wall Street
Price Targets
FAB Price Targets Summary
Fusion Antibodies PLC
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FAB's stock price target?
Not Available
FAB doesn't have any price targets made by Wall Street professionals.
What is Fusion Antibodies PLC's Revenue forecast?
Projected CAGR
86%
For the last 8 years the
compound annual growth rate for
Fusion Antibodies PLC's revenue is
-3%.
The projected
CAGR
for the next 1 year is
86%.